ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Prodigy Gold NL

Prodigy Gold NL (PRX)

0.002
0.00
( 0.00% )
Updated: 20:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.002
Bid
0.002
Ask
0.003
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.009
Market Cap
Previous Close
0.002
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
9,782,225
Shares Outstanding
2,013,773,990
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.01
Revenue
100k
Net Profit
-10.13M

About Prodigy Gold NL

Sector
Uranium-radium-vanadium Ores
Industry
Gold Ores
Headquarters
Darwin, Northern Territory, Aus
Founded
2006
Prodigy Gold NL is listed in the Uranium-radium-vanadium Ores sector of the Australian Stock Exchange with ticker PRX. The last closing price for Prodigy Gold NL was AUD0. Over the last year, Prodigy Gold NL shares have traded in a share price range of AUD 0.001 to AUD 0.009.

Prodigy Gold NL currently has 2,013,773,990 shares outstanding. The market capitalization of Prodigy Gold NL is AUD4.03 million. Prodigy Gold NL has a price to earnings ratio (PE ratio) of 0.00.

PRX Latest News

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Wednesday, February...

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA review WARREN, N.J., Jan. 5 /PRNewswire/ -- MonoSol...

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the third...

AstraZeneca Asks Court To Rule Quickly In Crestor Patent Row

AstraZeneca PLC (AZN) has asked a U.S. court for an early ruling on a patent dispute over the U.K. company's blockbuster statin Crestor which is being challenged by a number of generic firms...

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the second...

UPDATE: Watson Pharma 2Q Net Down 12%; Toprol Seen Boosting Fiscal Year

Watson Pharmaceuticals Inc. (WPI) reported a 12% drop in second-quarter earnings, due to items, but raised its 2009 financial expectations citing the expected approval of a generic version of...

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Tuesday, August 4...

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.001-33.33333333330.0030.0030.0015504015130.00186702DE
4000.0020.0050.001205912820.00239168DE
12-0.0005-200.00250.0050.00197822250.00236836DE
26000.0020.0050.00155973920.00240862DE
52-0.006-750.0080.0090.00140242980.00297032DE
156-0.031-93.93939393940.0330.0380.00117086810.00579533DE
260-0.091-97.84946236560.0930.0930.00114030760.02117579DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLZOBlaze Minerals Ltd
AUD 0.002
(100.00%)
55.17k
JAVOAJavelin Minerals Ltd
AUD 0.002
(100.00%)
2.5M
MNCMerino and Co Ltd
AUD 0.76
(72.73%)
343.74k
ORDOrdell Minerals Ltd
AUD 0.37
(68.18%)
9.31M
RFARare Foods Australia Ltd
AUD 0.043
(59.26%)
311.32k
NHEONoble Helium Ltd
AUD 0.002
(-60.00%)
260k
BITOCBiotron Ltd
AUD 0.001
(-50.00%)
439k
SFGSeafarms Group Limited
AUD 0.0015
(-50.00%)
47.5M
AEEOCAura Energy Limited
AUD 0.013
(-35.00%)
602.2k
IECIntra Energy Corporation Ltd
AUD 0.001
(-33.33%)
12.76M
TMKTMK Energy Ltd
AUD 0.0025
(0.00%)
213.53M
TMGTrigg Minerals Ltd
AUD 0.053
(6.00%)
64.49M
SGRStar Entertainment Group Limited
AUD 0.215
(-6.52%)
61.38M
MEKMeeka Metals Ltd
AUD 0.071
(-18.39%)
51.53M
SFGSeafarms Group Limited
AUD 0.0015
(-50.00%)
47.5M

Discussion

View Full Feed
oldstocks oldstocks 9 minutes ago
October 2, I asked about mingothings MTi
Southpaw is mingothings sl a
👍🏻
Or
👎
Type of company ?

I see they will be at the same place as DELL and OneMind Technologies SL on November 5-7 2024

Is MTi a competition
AFFU
ilovetech ilovetech 9 minutes ago
BP likes chasing low hanging fruit at great risk to its bottomline. Elli Lilly misses sales estimates for its two diabetes drug brands for weight loss by a shocking $900 million. Terminal disease is not a fad, and that's why I'm invested in NWBO.

https://futurism.com/neoscope/eli-lil
NWBO
4u2nv2 4u2nv2 12 minutes ago
Or maybe Ben did not like the deal the new guy proposed? Argentina? Try the DC area. Bold text says it all. Keep MCIC on watch.
MCIC
BDEZ BDEZ 13 minutes ago
Voting for Hovde on Tuesday...
Dingbatt Dingbatt 13 minutes ago
Doesn’t look like we will ever be able to afford to buy a race horse and put him on the race track at Tampa Bay because somebody stole the saddle and reigns and didn’t really buy the right oats
RNVA
BDEZ BDEZ 15 minutes ago
GA Resident says she has NEVER seen anything like the traffic the Trump rally just brought

https://x.com/WallStreetApes/status/1853290810940477610
marcis marcis 17 minutes ago
BS go to bed. I wake up to pee and you’re still spinning BS

Dude Orlando Taddeo has other companies.
Real DD in the EU community by someone where he has one of his main offices, has given him a 5 star for the company and the CEO

Also has Mexedia EU with current
RDAR
biotechinvestor1 biotechinvestor1 17 minutes ago
Halozyme is about to go through another major re-rating by the market; similar to what happened 2019-2020 when it went from $15 to $50. 

Folks are waking up to its amazing EPS growth and fat profit margin. 

Put a 20 multiple on the 2024 EPS of >$4 and you see we are hea
HALO
Vexari Vexari 19 minutes ago
When the environment of law enforcement

Becomes bifurcated

How would one know

Unless

It is lived
HoldEm777 HoldEm777 21 minutes ago
I suppose the entire deal could get put on ice that long because it can not be completed without it. Interesting point.
RDAR
blackhawks blackhawks 22 minutes ago
I think it's clear that the the VP elect is in line. But Chat suggests that the GOP could replace Vance with someone less f'd up.
BDEZ BDEZ 23 minutes ago
Maricopa County, here we go again

https://x.com/gatewaypundit/status/1853267995050508497
Moonboy1 Moonboy1 23 minutes ago
We will know soon enough. This will be all over the map for the next few days.
SHIBUSD
The Cardiac Kid The Cardiac Kid 24 minutes ago
But is the deal in default? It says October 28th but does not specify a year. I have read it multiple times myself. Are we just to assume 2024. We know what assuming does though haha. 🤔
RDAR
nnvcfan nnvcfan 26 minutes ago
Just as I thought AI knew better is how honest bashers and pumpers are!
NSAV
HoldEm777 HoldEm777 26 minutes ago
Yeah it’s almost as bad as HIRU. Geez what’s going on these days.
HIRU
Zorax Zorax 26 minutes ago
Is that speculation by chatg or does it actually have a data base of our entire congressional laws buried in some data bank somewhere?
Roman516 Roman516 29 minutes ago
NoGro,

Ok, but who owns the rights to DC?
https://nwbio.com/northwest-biotherapeutics-announces-exclusive-in-license-of-portfolio-of-dendritic-cell-technology-and-intellectual-property/
NWBO
Hopeforthefuture3 Hopeforthefuture3 30 minutes ago
Meirluc does not seem fair but I have heard 2 versions on the crossover. First was the fda required it and second was crossover was needed to get people to join the trial as no one wants to be the control.
Imo for such a deadly disease all trials should have to put all known data into a data
NWBO
Roman516 Roman516 31 minutes ago
Great Point,
https://nwbio.com/northwest-biotherapeutics-announces-exclusive-in-license-of-portfolio-of-dendritic-cell-technology-and-intellectual-property/
NWBO
blackhawks blackhawks 31 minutes ago
You said: What if trump dies on Tuesday and then he wins the election. Does Vance become president?

ChatGPT said:

If a presidential candidate were to pass away after winning an election, the line of succession depends on the timing and specific circumstances. In this hy
Fdc4 Fdc4 33 minutes ago
Yup and you did right. That ranch project seems like fairly tales dream anyways. The CEO said it, 10 years minimum to get things marching normal, who is going to pay for all that expenses? Shareholders of course. Frustrated is an understatement, he shall be embarrassed as well. It doesn’t take a ro
GTVH
janice shell janice shell 37 minutes ago
You are right. He doesn't really care what happened, or the reasons for it.
DR_rugby DR_rugby 39 minutes ago
Russian disinformation

https://m.youtube.com/watch?v=nxPdaoQIPz8

UBS swaps contracts termination

Little pump then

Interest rate reduction

Twenty days later margin calls

Santa rally hats for all
UBS

Your Recent History

Delayed Upgrade Clock